Role of Glycogen Synthase Kinase-3 in Insulin Resistance and Type 2 Diabetes

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-01 ,pp. : 1435-1441

Bentham Science Publishers

Access to resources Recommend Favorite

Challenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and Type 2 diabetes treatment

By Eldar-Finkelman Hagit   Ilouz Ronit  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1511-1519

Informa Healthcare

Access to resources Recommend Favorite

Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes

By MacAulay Katrina   Woodgett James R  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 10, 2008-10 ,pp. : 1265-1274

Informa Healthcare

Access to resources Recommend Favorite

Mechanisms linking diabetes mellitus to the development of atherosclerosis: a role for endoplasmic reticulum stress and glycogen synthase kinase-3

By Robertson Lindsie A.   Kim Anna J.   Werstuck Geoff H.  

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 1, 2006-01 ,pp. : 39-48

NRC Research Press

Access to resources Recommend Favorite

Vertex inhibitors of Aurora-2, glycogen synthase kinase-3 and Src kinase

By  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 3, 2004-03 ,pp. : 439-443

Informa Healthcare

Access to resources Recommend Favorite